NeuroSigma, Inc. is the creator of the Monarch Patient Care Program, offering an innovative non-medication treatment option for children with ADHD. Their Monarch eTNS System, a small device about the size of a cell phone, delivers low stimulating pulses to the trigeminal nerve through a patch placed on the child's forehead at bedtime, resulting in improved ADHD symptoms.
Backed by research funded by the National Institute of Mental Health, the Monarch eTNS System has shown significant effectiveness and tolerability in clinical trials, with a decrease in ADHD symptoms and a high responder rate. This noninvasive neuromodulation treatment device provides an alternative to medication for parents and caregivers who may have concerns about psychotropic drugs for their children.
Generated from the website